» Articles » PMID: 29518069

Vital Signs: Trends in Emergency Department Visits for Suspected Opioid Overdoses - United States, July 2016-September 2017

Overview
Date 2018 Mar 9
PMID 29518069
Citations 196
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: From 2015 to 2016, opioid overdose deaths increased 27.7%, indicating a worsening of the opioid overdose epidemic and highlighting the importance of rapid data collection, analysis, and dissemination.

Methods: Emergency department (ED) syndromic and hospital billing data on opioid-involved overdoses during July 2016-September 2017 were examined. Temporal trends in opioid overdoses from 52 jurisdictions in 45 states were analyzed at the regional level and by demographic characteristics. To assess trends based on urban development, data from 16 states were analyzed by state and urbanization level.

Results: From July 2016 through September 2017, a total of 142,557 ED visits (15.7 per 10,000 visits) from 52 jurisdictions in 45 states were suspected opioid-involved overdoses. This rate increased on average by 5.6% per quarter. Rates increased across demographic groups and all five U.S. regions, with largest increases in the Southwest, Midwest, and West (approximately 7%-11% per quarter). In 16 states, 119,198 ED visits (26.7 per 10,000 visits) were suspected opioid-involved overdoses. Ten states (Delaware, Illinois, Indiana, Maine, Missouri, Nevada, North Carolina, Ohio, Pennsylvania, and Wisconsin) experienced significant quarterly rate increases from third quarter 2016 to third quarter 2017, and in one state (Kentucky), rates decreased significantly. The highest rate increases occurred in large central metropolitan areas.

Conclusions And Implications For Public Health Practice: With continued increases in opioid overdoses, availability of timely data are important to inform actions taken by EDs and public health practitioners. Increases in opioid overdoses varied by region and urbanization level, indicating a need for localized responses. Educating ED physicians and staff members about appropriate services for immediate care and treatment and implementing a post-overdose protocol that includes naloxone provision and linking persons into treatment could assist EDs with preventing overdose.

Citing Articles

Cost-Effectiveness of Implementation Facilitation to Promote Emergency Department-Initiated Buprenorphine for Opioid Use Disorder.

Lu T, Ryan D, Cadet T, Chawarski M, Coupet E, Edelman E Ann Emerg Med. 2024; 85(3):205-213.

PMID: 39570250 PMC: 11845297. DOI: 10.1016/j.annemergmed.2024.10.001.


Overdose Experiences Among a Sample of Women in Jail with Opioid Use Disorder.

Dickson M, Annett J, Walker M, Leukefeld C, Webster J, Levi M Subst Use Misuse. 2024; 59(13):1911-1920.

PMID: 39069728 PMC: 11444883. DOI: 10.1080/10826084.2024.2383982.


Characteristics of Patients Presenting at an Emergency Department for a Heroin Overdose vs Detoxification.

Leonard K, Lynch J, Leong F, Kruger D, Clemency B Subst Abuse Rehabil. 2024; 15:79-85.

PMID: 38948167 PMC: 11214563. DOI: 10.2147/SAR.S461521.


Scaling Emergency Department Opioid Use Disorder Treatment Across California to Reduce Overdose Deaths, 2019-2023.

Samuels E, Rosen A, Speener M, Kaleekal J, Kalmin M, Goodman-Meza D Am J Public Health. 2024; 114(9):874-878.

PMID: 38935888 PMC: 11306617. DOI: 10.2105/AJPH.2024.307710.


Association Between Emergency Department Operational Metrics and Substance Use Disorder Treatment Interest in Two Rhode Island Hospitals.

Arbaugh S, Chambers L, Gaither R, Hallowell B, Daly M, Marshall B R I Med J (2013). 2024; 107(7):22-27.

PMID: 38917311 PMC: 11476007.


References
1.
Bowman S, Engelman A, Koziol J, Mahoney L, Maxwell C, McKenzie M . The Rhode Island community responds to opioid overdose deaths. R I Med J (2013). 2014; 97(10):34-7. View

2.
Ising A, Proescholdbell S, Harmon K, Sachdeva N, Marshall S, Waller A . Use of syndromic surveillance data to monitor poisonings and drug overdoses in state and local public health agencies. Inj Prev. 2016; 22 Suppl 1:i43-9. DOI: 10.1136/injuryprev-2015-041821. View

3.
Gould D, Walker D, Yoon P . The Evolution of BioSense: Lessons Learned and Future Directions. Public Health Rep. 2017; 132(1_suppl):7S-11S. PMC: 5676506. DOI: 10.1177/0033354917706954. View

4.
Coffin P, Tracy M, Bucciarelli A, Ompad D, Vlahov D, Galea S . Identifying injection drug users at risk of nonfatal overdose. Acad Emerg Med. 2007; 14(7):616-23. DOI: 10.1197/j.aem.2007.04.005. View

5.
Yoon P, Ising A, Gunn J . Using Syndromic Surveillance for All-Hazards Public Health Surveillance: Successes, Challenges, and the Future. Public Health Rep. 2017; 132(1_suppl):3S-6S. PMC: 5676514. DOI: 10.1177/0033354917708995. View